| Spirometry adherence | Oximetry Adherence | ||||
---|---|---|---|---|---|---|
Correlation | p | Correlation | p | |||
Age | 0.22 | 0.09 | 0.38 | 0.002 | ||
Baseline FVC | -0.17 | 0.21 | -0.13 | 0.34 | ||
Baseline FVC (% pred) | -0.05 | 0.71 | -0.11 | 0.42 | ||
Baseline TLCO | -0.12 | 0.36 | -0.19 | 0.14 | ||
ILD-GAP score | 0.2903 | 0.02 | 0.38 | 0.003 | ||
ILD-GAP stage | 0.24 | 0.056 | 0.300 | 0.02 | ||
Baseline EQ-5D-5 L index score (n = 46) | 0.18 | 0.23 | 0.19 | 0.21 | ||
Baseline vas | 0.446 | 0.03 | 0.4632 | 0.03 | ||
 | n | Median (IQR) | P | Median (IQR) | P | |
Gender†| Male | 42 | 90 (73–95) | 0.86 | 91 (74–97) | 0.35 |
Female | 18 | 88 (72–95) | 86.5 (75.25–94.5) | |||
Ethnicity†| White | 49 | 93 (74–97) | 0.02 | 92 (76–97) | 0.04 |
Asian | 6 | 89.5 (88–91.75) | 89.5 (87.25–91.75) | |||
Black/Other / Not reported | 5 | 34 (19–38) | 38 (33–71) | |||
IPF vs. non-IPF†| IPF | 34 | 92 (77.5-97.25) | 0.08 | 92 (82.5–98) | 0.07 |
Non IPF -ILD | 26 | 79.5 (53.25–95.25 | 85 (59.25–95.25) | |||
ILD subtype†| IPF | 34 | 80.5 (43.25–93.75) | 0.046 | 92 (82.5–98) | 0.24 |
CTD-ILD | 7 | 95(82–97) | 95 (82–97) | |||
CHP | 5 | 92(58–95) | 92 (58.5–95.5) | |||
RA-ILD | 6 | 51.5 (40.75–70.75) | 72.5 (46-88.25) | |||
Other | 8 | 85 (44-96.5) | 80.5 (43.25–93.75) |